Optoceutics ApS

Private limited companyCVR 39769689København NActive

Optoceutics ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2018. The company made a loss in both 2024 and 2025, most recently DKK 8.7m.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 2.6m−397.9% vs. 2024
Net profit−DKK 8.7m+4.9% vs. 2024
EquityDKK 32.3m−5.1% vs. 2024
Employees5latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 9.2m to DKK 8.7m (2024 → 2025).
  • Equity fell 5% (2024 → 2025), to DKK 32.3m.

Employees

  • 1 fewer employees than a year earlier: 5 (07/2026) against 6 (07/2025).

Management and owners, last 24 months

  • New in management: Jes Broeng (chair of the board, 20/05/2025).
  • Stepped down: Jes Broeng (board member, 19/05/2025), David Lee Hardwick (chair of the board, 13/05/2025) and Jes Broeng (chair of the board, 21/09/2026).
  • New owners registered: M. S. C. Holding ApS (30/12/2024) and Danielsen 2 ApS (29/07/2026).
  • No longer registered as owner: Broeng Consult ApS (30/12/2024), M. S. C. Holding ApS (29/12/2024) and Danielsen 2 ApS (28/07/2026).

Registrations, last 24 months

  • 29/07/2026: Share capital changed from 108,991 DKK to 111,753 DKK
  • 06/03/2026: Share capital changed from 106,229 DKK to 108,991 DKK
  • 27/11/2025: Share capital changed from 104,295 DKK to 106,229 DKK
  • 24/03/2025: Moved to Nørrebrogade 45C, 4. tv, 2200 København N
  • 14/01/2025: Share capital changed from 103,301 DKK to 104,295 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 10mDKK 0DKK 10mDKK 20mDKK 30m202020212022202320242025
EquityNet profit
Financial figures for Optoceutics ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−132−2,1774,263910−519−2,586−397.9%
Operating profit (EBIT)−953−5,418––−9,306−8,440+9.3%
Profit before tax−1,030−5,486−5,052−8,633−10,068−9,205+8.6%
Net profit−506−3,880−3,636−7,212−9,185−8,736+4.9%
Total assets27,26926,44629,92640,81646,02343,578−5.3%
Equity16,24813,36716,94328,91434,06432,320−5.1%
Liabilities9,74112,070––11,95911,257−5.9%
Cash and cash equivalents17,05811,9149,8774,3198,9144,991−44%
Average number of employees6101414117−36.4%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1mDKK 2mDKK 3mDKK 4m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Fewer employees

    The number of employees fell 36% from 11 in 2024 to 7 in 2025.

    How is this calculated?

    The number of employees according to the annual report has fallen by at least 25%, and was at least 10 the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Optoceutics ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202530/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202426/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202309/07/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202205/07/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202118/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202006/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101214161808/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 2.6mNo. 357 of 421
Better than 15% of the companies in the industry
EquityDKK 32.3mNo. 77 of 431
Better than 82% of the companies in the industry
Number of employees5No. 173 of 431
Better than 60% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,305of 69,742
Better than 1%
No. 4,225of 69,964
Better than 94%
Same industry and fewer than 20 employees329 companies in the comparison
No. 278of 323
Better than 14%
No. 23of 329
Better than 93%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,334of 33,588
Better than 1%
No. 1,665of 33,687
Better than 95%
All companies of type ApS66,508 companies in the comparison
No. 66,018of 66,379
Better than 1%
No. 2,975of 66,505
Better than 96%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Optoceutics ApS−DKK 2.6m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Optoceutics ApS−DKK 8.7m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Optoceutics ApSDKK 32.3m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Optoceutics ApS5
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Optoceutics ApS

Management

6 active registrations

Executive management

Executive management at Optoceutics ApS
NameRoleAppointed
Ngoc Mai Thi NguyenCEO09/08/2018
Marcus Schultz CarstensenDirector08/06/2019

Board of directors

Board of directors at Optoceutics ApS
NameRoleAppointed
Marcus Schultz CarstensenBoard member05/03/2019
Ngoc Mai Thi NguyenBoard member05/03/2019
Vivienne L'Ecuyer MingBoard member22/07/2019
Kaare Agerholm DanielsenBoard member01/09/2020
Founders
M. S. C. Holding ApS
Former management (6)
Former management at Optoceutics ApS
NameRoleAppointedResigned
Marcus Schultz CarstensenCEO08/08/201809/08/2018
Jes BroengBoard member05/03/201919/05/2025
Rasmus JustChair of the board05/03/201908/11/2023
David Lee HardwickBoard member07/09/202307/11/2023
David Lee HardwickChair of the board08/11/202313/05/2025
Jes BroengChair of the board20/05/202521/09/2026

Signing rule: Selskabet tegnes af en direktør i forening med bestyrelsens formand, af tre medlemmer af bestyrelsen i forening, eller af den samlede bestyrelse

Address and production units

1 active production units

Nørrebrogade 45C
2200 København N

København Municipality · Postcode 2200

Production units
Production unitAddressEmployeesP number
Optoceutics ApSNørrebrogade 45C, 4. tv, 2200 København N61023848607

Purpose

Selskabets formål er at drive kommerci-el virksomhed inden for højteknologiske produkter og serviceydelser baseret på lys-baserede produkter til kognitive for-bedringer og neurologisk behandling samt enhver aktivitet, der efter bestyrel-sens skøn står i forbindelse hermed

The purpose is quoted from the register in Danish.

Changes year by year

80 registered events
20266 changesmanagement 1 · capital 2 · ownership 2 · accounts 1
  • Jes Broeng stepped down as chair of the board
  • Share capital changed from 108,991 DKK to 111,753 DKK
  • Danielsen 2 ApS registered as owner (33.33%)
  • Danielsen 2 ApS is no longer registered as owner
  • Annual report for 2025 published
  • Share capital changed from 106,229 DKK to 108,991 DKK
20258 changescapital 2 · accounts 1 · management 3 · address 1 · industry 1
  • Share capital changed from 104,295 DKK to 106,229 DKK
  • Annual report for 2024 published
  • Jes Broeng appointed chair of the board
  • Jes Broeng stepped down as board member
  • David Lee Hardwick stepped down as chair of the board
  • Moved to Nørrebrogade 45C, 4. tv, 2200 København N
  • Share capital changed from 103,301 DKK to 104,295 DKK
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20246 changescapital 1 · ownership 3 · address 1 · accounts 1
  • Share capital changed from 97,009 DKK to 103,301 DKK
  • M. S. C. HOLDING ApS registered as owner (10%)
  • BROENG CONSULT ApS is no longer registered as owner
  • M. S. C. HOLDING ApS is no longer registered as owner
  • Moved to Nørrebrogade 45C, 4. tv, 2200 København N
  • Annual report for 2023 published
20239 changescapital 3 · ownership 1 · management 4 · accounts 1
  • Share capital changed from 92,317 DKK to 97,009 DKK
  • Sebastian Scripps registered as owner (5%)
  • David Lee Hardwick appointed chair of the board
  • Rasmus Just stepped down as chair of the board
  • David Lee Hardwick stepped down as board member
  • Share capital changed from 92,086 DKK to 92,317 DKK
  • David Lee Hardwick appointed board member
  • Annual report for 2022 published
  • Share capital changed from 89,033 DKK to 92,086 DKK
20227 changescapital 1 · ownership 2 · accounts 1 · address 2 · industry 1
  • Share capital changed from 82,902 DKK to 89,033 DKK
  • Ngoc Mai Thi Nguyen registered as owner (15%)
  • Ngoc Mai Thi Nguyen is no longer registered as owner
  • Annual report for 2021 published
  • Moved to Gammel Kongevej 1, 4. tv, 1610 København V
  • Moved to Gammel Kongevej 1, 4. tv, 1610 København V
  • Industry changed to Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)
20212 changesaccounts 1 · capital 1
  • Annual report for 2020 published
  • Share capital changed from 82,052 DKK to 82,902 DKK
202012 changesownership 8 · capital 3 · management 1
  • Ngoc Mai Thi Nguyen is no longer registered as owner
  • Share capital changed from 73,309 DKK to 82,052 DKK
  • Kaare Agerholm Danielsen appointed board member
  • M. S. C. HOLDING ApS registered as owner (15%)
  • Danielsen 2 ApS registered as owner (25%)
  • LUCAS INNOVATION ApS is no longer registered as owner
  • Lunox ApS is no longer registered as owner
  • M. S. C. HOLDING ApS is no longer registered as owner
  • Danielsen 2 ApS is no longer registered as owner
  • Share capital changed from 71,988 DKK to 73,309 DKK
  • Share capital changed from 68,654 DKK to 71,988 DKK
  • Vjack Holding ApS registered as owner (5%)
201917 changescapital 3 · management 6 · ownership 8
  • Share capital changed from 56,964 DKK to 68,654 DKK
  • Vivienne L'Ecuyer Ming appointed board member
  • M. S. C. HOLDING ApS registered as owner (20%)
  • Danielsen 2 ApS registered as owner (15%)
  • CHRISTIAN NIELSENS FOND is no longer registered as owner
  • Marcus Schultz Carstensen is no longer registered as owner
  • M. S. C. HOLDING ApS is no longer registered as owner
  • Marcus Schultz Carstensen appointed director
  • Share capital changed from 53,888 DKK to 56,964 DKK
  • CHRISTIAN NIELSENS FOND registered as owner (5%)
  • Share capital changed from 50,000 DKK to 53,888 DKK
  • Rasmus Just appointed chair of the board
  • Jes Broeng appointed board member
  • Marcus Schultz Carstensen appointed board member
  • Ngoc Mai Thi Nguyen appointed board member
  • Vjack Holding ApS is no longer registered as owner
  • Vjack Holding ApS registered as owner (10%)
201813 changesname 1 · capital 1 · ownership 6 · address 1 · management 3 · founded 1
  • Name changed from Optoceutics IVS to Optoceutics ApS
  • Share capital changed from 1 DKK to 50,000 DKK
  • Ngoc Mai Thi Nguyen registered as owner (20%)
  • LUCAS INNOVATION ApS registered as owner (5%)
  • BROENG CONSULT ApS registered as owner (5%)
  • Lunox ApS registered as owner (5%)
  • Moved to Diplomvej 381, 2800 Kongens Lyngby
  • Ngoc Mai Thi Nguyen appointed ceo
  • Marcus Schultz Carstensen stepped down as ceo
  • Registered as Optoceutics IVS
  • Marcus Schultz Carstensen appointed ceo
  • Marcus Schultz Carstensen registered as owner (25%)
  • M. S. C. HOLDING ApS registered as owner (25%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction